Oncoscience AG
🇨🇭Switzerland
Clinical Trials
8
Active:4
Completed:4
Trial Phases
2 Phases
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 3
1 (50.0%)Nimotuzumab in Adults With Glioblastoma Multiforma
- First Posted Date
- 2008-09-16
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- Oncoscience AG
- Target Recruit Count
- 150
- Registration Number
- NCT00753246
- Locations
- 🇩🇪
Dep. Neurosurgery, Univ. Hamburg, Hamburg, Germany
Nimotuzumab in Children With Intrinsic Pontine Glioma
Completed
- Conditions
- Diffuse Instrinsic Ponitine Glioma
- First Posted Date
- 2007-11-21
- Last Posted Date
- 2013-03-29
- Lead Sponsor
- Oncoscience AG
- Target Recruit Count
- 41
- Registration Number
- NCT00561691
- Locations
- 🇩🇪
University Bonn, Children's Medical Hospital, Bonn, Germany
Nimotuzumab in Children With HGG
Completed
- Conditions
- High Grade Glioma
- First Posted Date
- 2007-11-21
- Last Posted Date
- 2007-11-21
- Lead Sponsor
- Oncoscience AG
- Target Recruit Count
- 45
- Registration Number
- NCT00561873
- Locations
- 🇩🇪
University Bonn, Children's Medical Hospital, Bonn, Germany
Nimotuzumab in Adults With Pancreatic Cancer
- First Posted Date
- 2007-11-21
- Last Posted Date
- 2015-10-15
- Lead Sponsor
- Oncoscience AG
- Target Recruit Count
- 188
- Registration Number
- NCT00561990
- Locations
- 🇩🇪
Marienhospital Herne, Herne, Germany
News
No news found